Grant opportunity · PAR-25-059
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
Who can apply (as listed)
- State governments
- Nonprofits with 501(c)(3) status (other than institutions of higher education)
- Small businesses
- Special district governments
- Native American tribal organizations (other than federally recognized governments)
- Native American tribal governments (federally recognized)
- Public and state-controlled institutions of higher education
- Public housing authorities / Indian housing authorities
- Others (see the opportunity text)
- County governments
- City or township governments
- Nonprofits without 501(c)(3) status (other than institutions of higher education)
- Private institutions of higher education
- For-profit organizations (other than small businesses)
- Independent school districts
This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize potential therapeutic agents for neurological or neuromuscular disorders. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) to advance projects to the point where they can meet the entry criteria for the Blueprint Neurotherapeutics Network (BPN) or other translational programs.
Excerpt as published. The full synopsis, required forms, and any amendments are on the official listing.
GrantSet indexes public records and is not the official application channel. Responses and applications go through Grants.gov only — the official notice there controls if anything shown here differs.